Muscle strength in breast cancer patients receiving different treatment regimes
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Background: Muscle dysfunction and sarcopenia have been associated with poor performance status, an increased mortality risk, and greater side effects in oncologic patients. However, little is known about how performance is affected by cancer therapy. We investigated muscle strength in breast cancer patients in different adjuvant treatment settings and also compared it with data from healthy individuals. Methods: Breast cancer patients ( N = 255) from two randomized controlled exercise trials, staged 0–III and aged 54.4 ± 9.4 years, were categorized into four groups according to their treatment status. In a cross‐sectional design, muscle function was assessed bilaterally by isokinetic dynamometry (0°, 60°, 180°/s) as maximal voluntary isometric contraction (MVIC) and maximal isokinetic peak torque (MIPT) in shoulder rotators and knee flexors and extensors. Additionally, muscular fatigue index (FI%) and shoulder flexibility were evaluated. Healthy women ( N = 26), aged 53.3 ± 9.8 years, were tested using the same method. Analysis of covariance was used to estimate the impact of different cancer treatments on skeletal muscle function with adjustment for various clinical and socio‐demographic factors. Results: Consistently, lower muscle strength was measured in shoulder and knee strength in patients after chemotherapy. On average, patients had up to 25% lower strength in lower extremities and 12–16% in upper extremities in MVIC and MIPT during cancer treatment compared with healthy women. No substantial difference between patient groups in shoulder strength, but significantly lower shoulder flexibility in patients with radical mastectomy was measured. Chemotherapy‐treated patients had consistently higher FI%. No serious adverse events were reported. Conclusions: Breast cancer patients showed markedly impaired muscle strength and joint dysfunctions before and after anticancer treatment. The significant differences between patients and healthy individuals underline the need of exercise therapy as early as possible in order to prevent or counteract the loss of muscle function after curative surgery as well as the consequences of neo‐/adjuvant chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Fielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256
Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238 · cited 2×
“Sarcopenia is an independent predictor of survival, which is closely related to patients’ functional status and potentially to CT toxicity.(38,39) In average, nearly all evaluated BC groups in our study had indications for sarcopenia because of impaired muscle strength and function,(40) and those who had received CT i…”
Newman, A. B., Kupelian, V., Visser, M., Simonsick, E. M., Goodpaster, B. H., Kritchevsky, S. B., Tylavsky, F. A., Rubin, S. M., Harris, T. B., & on Behalf of the Health, A. A. B. C. S. I. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.1.72 · Cited by 1,692 · cited 1×
“With regard to healthy older individuals, muscle strength, but not mass, was identified as a strong independent predictor of all-cause mortality.(9) Based on the current knowledge of treatment-related side effects, it can be assumed that muscle function is affected by different cancer treatments.”
Courneya, K. S., Segal, R. J., Mackey, J. R., Gelmon, K., Reid, R. D., Friedenreich, C. M., Ladha, A. B., Proulx, C., Vallance, J. K. H., Lane, K., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2024 · Cited by 1,179
Prado, C. M. M., Baracos, V. E., McCargar, L. J., Reiman, T., Mourtzakis, M., Tonkin, K., Mackey, J. R., Koski, S., Pituskin, E., & Sawyer, M. B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2242 · Cited by 1,104 · cited 3×
“Furthermore, it was shown that skeletal muscle status is of clinical relevance because it is associated with treatment complications and time-to-tumour progression.(8) With regard to healthy older individuals, muscle strength, but not mass, was identified as a strong independent predictor of all-cause mortality.”
A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women
Frontera, W. R., Hughes, V. A., Lutz, K. J., & Evans, W. J. (1991) · Journal of Applied Physiology · doi:10.1152/jappl.1991.71.2.644 · Cited by 1,011 · cited 1×
“Nevertheless, the strength performance of our healthy participants was in line with comparably aged healthy women.(49) We also found significant age differences between the treatment groups showing a higher age in the non-CT group.”
Physical Activity, Biomarkers, and Disease Outcomes in Cancer Survivors: A Systematic Review
Ballard-Barbash, R., Friedenreich, C. M., Courneya, K. S., Siddiqi, S. M., McTiernan, A., & Alfano, C. M. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs207 · Cited by 831
van Waart, H., Stuiver, M. M., van Harten, W. H., Geleijn, E., Kieffer, J. M., Buffart, L. M., de Maaker-Berkhof, M., Boven, E., Schrama, J., Geenen, M. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.1081 · Cited by 644
Schmid, D., & Leitzmann, M. F. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu012 · Cited by 625
Signaling pathways controlling skeletal muscle mass
Egerman, M. A., & Glass, D. J. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.857291 · Cited by 555 · cited 1×
“Other possible pathways could be up-regulating processes of muscle-specific enzymes (E3 ubiquitin ligase atrogin1/muscle atrophy F-box) through the proteasome pathway, the activation of caspase by oxidant-mediated apoptosis, and the formation of reactive oxygen species in muscle stimulating apoptosis in skeletal myocy…”
Demark-Wahnefried, W., Peterson, B. L., Winer, E. P., Marks, L., Aziz, N., Marcom, P. K., Blackwell, K., & Rimer, B. K. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.9.2381 · Cited by 545 · cited 1×
“Breat cancer patients undergoing adjuvant chemotherapy (CT) reduce their daily energy expenditure during therapy, which is associated with a loss of muscle mass.(6,7) Furthermore, it was shown that skeletal muscle status is of clinical relevance because it is associated with treatment complications and time-to-tumour…”
Body composition and outcome in patients undergoing resection of colorectal liver metastases19
van Vledder, M. G., Levolger, S., Ayez, N., Verhoef, C., Tran, T. C. K., & IJzermans, J. N. M. (2012) · British Journal of Surgery · doi:10.1002/bjs.7823 · Cited by 462 · cited 2×
“Sarcopenia is an independent predictor of survival, which is closely related to patients’ functional status and potentially to CT toxicity.(38,39) In average, nearly all evaluated BC groups in our study had indications for sarcopenia because of impaired muscle strength and function,(40) and those who had received CT i…”
Isokinetic Evaluation of Muscular Performance
Kannus, P. (1994) · International Journal of Sports Medicine · doi:10.1055/s-2007-1021104 · Cited by 444
Hayes, S. C., Johansson, K., Stout, N. L., Prosnitz, R., Armer, J. M., Gabram, S., & Schmitz, K. H. (2012) · Cancer · doi:10.1002/cncr.27467 · Cited by 366 · cited 1×
“Aside from reduced strength capacity, upper-body mobility restrictions represent a stressful physical limitation in patients undergoing BC surgery.(47) We measured a loss of shoulder mobility and decreased shoulder internal rotator strength, resulting in an impaired shoulder function, which may be a result of mastecto…”
Chemotherapy-Induced Weakness and Fatigue in Skeletal Muscle: The Role of Oxidative Stress
Gilliam, L. A. A., & St. Clair, D. K. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3965 · Cited by 324 · cited 1×
“It is supposed that CT causes oxidative stress to normal tissue and directly impacts skeletal muscles and fatigue.(34,36) Other possible pathways could be up-regulating processes of muscle-specific enzymes (E3 ubiquitin ligase atrogin1/muscle atrophy F-box) through the proteasome pathway, the activation of caspase by…”
Impact of Resistance Training in Cancer Survivors: A Meta-Analysis
STRASSER, B., STEINDORF, K., WISKEMANN, J., & ULRICH, C. M. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31829a3b63 · Cited by 291 · cited 1×
“Currently, there is insufficient knowledge on influence of cancer treatment on muscle function and strength in patients undergoing BC treatment.(13) Since we recently reported that cardiorespiratory performance varies between patient groups defined by cancer treatment,(14) we would like to provide an overall picture o…”
Self-citationPrevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study
Villaseñor, A., Ballard-Barbash, R., Baumgartner, K., Baumgartner, R., Bernstein, L., McTiernan, A., & Neuhouser, M. L. (2012) · Journal of Cancer Survivorship · doi:10.1007/s11764-012-0234-x · Cited by 274 · cited 3×
“86 in BC survivors.(1) Low muscle strength and physical inactivity can be a predictor for persistent fatigue in older, long-term BC survivors.”
Fairey, A. S., Courneya, K. S., Field, C. J., Bell, G. J., Jones, L. W., & Mackey, J. R. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00566.2004 · Cited by 271
Effects of Exercise during Adjuvant Chemotherapy on Breast Cancer Outcomes
COURNEYA, K. S., SEGAL, R. J., MCKENZIE, D. C., DONG, H., GELMON, K., FRIEDENREICH, C. M., YASUI, Y., REID, R. D., CRAWFORD, J. J., & MACKEY, J. R. (2014) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000297 · Cited by 267 · cited 1×
“This postulation is supported by RCT data suggesting that adding resistance training to standard CT may improve CT completion rate(11,42) as well as BC outcomes.(12) Hereby, reduced systemic inflammation(43) modulate the insulin pathway,(44) favourably affect cell-mediated immunity,(45) and change steroid hormone leve…”
Kilgour, R. D., Vigano, A., Trutschnigg, B., Lucar, E., Borod, M., & Morais, J. A. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-1894-4 · Cited by 255
Schroevers, M. J., Sanderman, R., van Sonderen, E., & Ranchor, A. V. (2000) · Quality of Life Research · doi:10.1023/a:1016673003237 · Cited by 249
Steindorf, K., Schmidt, M. E., Klassen, O., Ulrich, C. M., Oelmann, J., Habermann, N., Beckhove, P., Owen, R., Debus, J., Wiskemann, J., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu374 · Cited by 249
Self-citationMuscle dysfunction in cancer patients
Christensen, J. F., Jones, L. W., Andersen, J. L., Daugaard, G., Rorth, M., & Hojman, P. (2014) · Annals of Oncology · doi:10.1093/annonc/mdt551 · Cited by 242 · cited 3×
“The use of isokinetic dynamometer is considered a gold standard method to evaluate strength in cancer patients.(2) It has already been shown to be valid and reliable in healthy subjects(21) and has been used previously in various cancer populations.”
von Haehling, S., Morley, J. E., Coats, A. J. S., & Anker, S. D. (2015) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12089 · Cited by 199
Fairey, A. S., Courneya, K. S., Field, C. J., Bell, G. J., Jones, L. W., Martin, B. S., & Mackey, J. R. (2005) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.04.001 · Cited by 199
Galvão, D. A., Taaffe, D. R., Spry, N., Joseph, D., Turner, D., & Newton, R. U. (2009) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2008.51 · Cited by 198 · cited 1×
“However, most published studies in the field assessed strength performance via handgrip(26) or handheld dynamometry,(27,28) with functional tests(5) or by using the one repetition maximum method.(29,30) There are also studies using isokinetic testing procedures, but these studies had low sample sizes, and focused on o…”
Scott, J. M., Khakoo, A., Mackey, J. R., Haykowsky, M. J., Douglas, P. S., & Jones, L. W. (2011) · Circulation · doi:10.1161/circulationaha.111.021774 · Cited by 188 · cited 1×
“This is supported by the observation that CT caused severe reductions in myofibre size, neurogenic alterations, and mitochondria-related damages in mice as well as in humans.(2,35) Furthermore, it is well known that BC patients reduce their physical activity level during the period of cancer treatment.”
Kilgour, R. D., Vigano, A., Trutschnigg, B., Hornby, L., Lucar, E., Bacon, S. L., & Morais, J. A. (2010) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-010-0016-0 · Cited by 175
Exercise rehabilitation in patients with cancer
Lakoski, S. G., Eves, N. D., Douglas, P. S., & Jones, L. W. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.27 · Cited by 165
Harrington, S., Padua, D., Battaglini, C., Michener, L. A., Giuliani, C., Myers, J., & Groff, D. (2011) · Journal of Cancer Survivorship · doi:10.1007/s11764-010-0168-0 · Cited by 159 · cited 4×
“A recent study by Harrington et al.(28) presented complex analyses using a score (with usage of questionnaires, multiple flexion movements, and MVIC with a handheld dynamometer) for disabilities in shoulder of BC survivors (N = 24) in a similar timeframe after surgery.”
InfluentialEffect of Exercise on Serum Androgens in Postmenopausal Women: A 12-Month Randomized Clinical Trial
McTiernan, A., Tworoger, S. S., Rajan, K. B., Yasui, Y., Sorenson, B., Ulrich, C. M., Chubak, J., Stanczyk, F. Z., Bowen, D., Irwin, M. L., et al. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.1099.13.7 · Cited by 148
Self-citationMuscular Strength and Adiposity as Predictors of Adulthood Cancer Mortality in Men
Ruiz, J. R., Sui, X., Lobelo, F., Lee, D.-C., Morrow, J. R., Jackson, A. W., Hébert, J. R., Matthews, C. E., Sjöström, M., & Blair, S. N. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-1075 · Cited by 142
Kootstra, J. J., Dijkstra, P. U., Rietman, H. S., de Vries, J., Baas, P. C., Geertzen, J. H. B., Hoekstra, H. J., & Hoekstra‐Weebers, J. E. H. M. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2509-y · Cited by 127 · cited 1×
“Impaired shoulder function has been reported in many BC survivors even several years after surgery.(48) A recent study by Harrington et al.”
Schneider, C., Hsieh, C. C., Sprod, L. K., Carter, S. D., & Hayward, R. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm364 · Cited by 119
Strength, Physical Activity, and Age Predict Fatigue in Older Breast Cancer Survivors
Winters‐Stone, K. M., Bennett, J. A., Nail, L. M., & Schwartz, A. L. (2008) · Oncology nursing forum · doi:10.1188/08.onf.815-821 · Cited by 116 · cited 1×
“Low muscle strength and physical inactivity can be a predictor for persistent fatigue in older, long-term BC survivors.(5) Breat cancer patients undergoing adjuvant chemotherapy (CT) reduce their daily energy expenditure during therapy, which is associated with a loss of muscle mass.”
Weber, M.-A., Krakowski-Roosen, H., Schröder, L., Kinscherf, R., Krix, M., Kopp-Schneider, A., Essig, M., Bachert, P., Kauczor, H.-U., & Hildebrandt, W. (2009) · Acta Oncologica · doi:10.1080/02841860802130001 · Cited by 109
Huy, C., Schmidt, M. E., Vrieling, A., Chang-Claude, J. C., & Steindorf, K. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.08.005 · Cited by 109 · cited 2×
“Furthermore, it is well known that BC patients reduce their physical activity level during the period of cancer treatment.(7) Moreover, our Ta b le 1 (c o n ti nu ed ) To ta l Br ea st ca nc er tr ea tm en t gr ou ps H ea lt hy”
Self-citationCardiorespiratory fitness in breast cancer patients undergoing adjuvant therapy
Klassen, O., Schmidt, M. E., Scharhag‐Rosenberger, F., Sorkin, M., Ulrich, C. M., Schneeweiß, A., Potthoff, K., Steindorf, K., & Wiskemann, J. (2014) · Acta Oncologica · doi:10.3109/0284186x.2014.899435 · Cited by 86
Self-citationPotthoff, K., Schmidt, M. E., Wiskemann, J., Hof, H., Klassen, O., Habermann, N., Beckhove, P., Debus, J., Ulrich, C. M., & Steindorf, K. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-162 · Cited by 60 · cited 1×
“Further, inclusion and exclusion criteria and more details of the RCTs are presented elsewhere.(15,16) In a parallel intervention study (INVEST study) with identical surveys, 26 healthy age-matched control women participated in the same 12-week progressive resistance training protocol to obtain comparison data.”
Self-citationMüller, S. (2001) · Pflege · doi:10.1024/1012-5302.14.3.161 · Cited by 58
Schmidt, M. E., Wiskemann, J., Krakowski‐Roosen, H., Knicker, A. J., Habermann, N., Schneeweiß, A., Ulrich, C. M., & Steindorf, K. (2012) · Contemporary Clinical Trials · doi:10.1016/j.cct.2012.10.006 · Cited by 50 · cited 1×
“Further, inclusion and exclusion criteria and more details of the RCTs are presented elsewhere.(15,16) In a parallel intervention study (INVEST study) with identical surveys, 26 healthy age-matched control women participated in the same 12-week progressive resistance training protocol to obtain comparison data.”
Self-citationFong, S. S. M., Ng, S. S. M., Luk, W. S., Chung, J. W. Y., Chung, L. M. Y., Tsang, W. W. N., & Chow, L. P. Y. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/787169 · Cited by 50
Jones, L. W., Mourtzakis, M., Peters, K. B., Friedman, A. H., West, M. J., Mabe, S., Kraus, W. E., Friedman, H. S., & Reardon, D. A. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0265 · Cited by 31
Isometric strength measurement for muscle weakness in cancer patients
Knols, R. H., Stappaerts, K. H., Fransen, J., Uebelhart, D., & Aufdemkampe, G. (2002) · Supportive Care in Cancer · doi:10.1007/s00520-002-0343-6 · Cited by 27 · cited 2×
“locoregional and systemic therapies and cancer-related fatigue).(33) Receiving chemotherapy might be one of the most important factors as we already reported for cardiorespiratory fitness,(14) but the mechanisms and pathways of cancer treatment influences on muscle structure and function are not completely understood.”
Physical Performance and Psychosocial Status in Lung Cancer Patients: Results from a Pilot Study
Hummler, S., Thomas, M., Hoffmann, B., Gärtner, P., Zoz, M., Huber, G., Ulrich, C. M., & Wiskemann, J. (2014) · Oncology Research and Treatment · doi:10.1159/000358157 · Cited by 23
Self-citationPrediction of Response to Neoadjuvant Chemotherapy: New Biomarker Approaches and Concepts
Denkert, C., Sinn, B. V., Issa, Y., Müller, B. M., Maisch, A., Untch, M., von Minckwitz, G., & Loibl, S. (2011) · Breast Care · doi:10.1159/000331696 · Cited by 19
Cited by
Hand grip strength as a proposed new vital sign of health: a narrative review of evidences
Vaishya, R., Misra, A., Vaish, A., Ursino, N., & D’Ambrosi, R. (2024) · Journal of Health, Population and Nutrition · doi:10.1186/s41043-024-00500-y · Cited by 385
“On average, patients had up to 25% lower strength in their lower extremities and 12–16% in their upper extremities, during cancer treatment compared with healthy women [116].”
Background
Metadata
- Authors
- Klassen, O., Schmidt, M. E., Ulrich, C. M., Schneeweiss, A., Potthoff, K., Steindorf, K., & Wiskemann, J.
- Venue
- Journal of Cachexia, Sarcopenia and Muscle
- Publisher
- Wiley
- Published
- 2016-11-28
- Volume
- 8
- Issue
- 2
- Pages
- 305-316
- ISSN
- 2190-5991 (ISSN-L)
- 2190-6009
- OpenAlex
- W2557299371
- Cited by
- 232
- References
- 47
- FWCI
- 8.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.